Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2013

Nov 8, 2013

32853_dirs_2013-11-08_660dd1e6-25c7-44b5-b421-122abb26220e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2013-11-01

Reporting Person: COLELLA SAMUEL D (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-04 Common Stock J 4297 Acquired 5561 Indirect
2013-11-04 Common Stock J 8796 Acquired 19673 Direct

Footnotes

F1: The shares are held by Colella Family Partners, L.P. ("Colella Partners"). The shares were received in in-kind distributions by Versant Ventures I, LLC, which is the general partner of each of Versant Venture Capital I, L.P., Versant Side Fund I, L.P., Versant Affiliates Fund I-A, L.P. and Versant Affiliates Fund I-B, L.P. (collectively, the "Versant Funds"), on November 4, 2013. The Reporting Person is the General Partner of Colella Partners. The Reporting Person disclaims beneficial ownership of such shares held by Colella Partners, except to the extent of his proportionate pecuniary interest therein, if any.

F2: The shares are held by the Colella Family Trust UTA Dtd. 9/21/92 ("Colella Trust"). The shares were received in in-kind distributions by Versant Ventures I, LLC, which is the general partner of each of the Versant Funds, on November 4, 2013. The Reporting Person is a trustee and beneficiary of the Colella Trust.

F3: This amendment is filed to correctly report the number of shares acquired by the Reporting Person on November 4, 2013.